Alan Fournier's portfolio and holdings - Aug 2024

As per corporate shareholdings filed for , people matching Alan Fournier publicly holds 39 stocks with a net worth of over US$ 696.6 M.

These are shares held by Alan Fournier as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.

Get a Portfolio in one click
Trendlyne RA Baskets
ADD ALL SUPERSTAR ALERTS
Stock Name Holders Name Current Price US$ Quantity Held Holding Percent Change from Previous Qtr Holding Value US$ History
Perimeter Solutions SA Pennant Investors Lp 28.05 2,300,000 1.58% 0.00 64.5 M
ODP Corporation (The) Pennant Investors Lp 27.97 400,000 1.33% 0.14 11.2 M
EchoStar Corp - Ordinary Shares - Class A Pennant Investors Lp 74.50 2,153,209 0.79% 0.00 160.4 M
FibroGen Inc Pennant Investors Lp 8.25 768,400 0.76% -0.01 6.3 M
Antero Resources Corp Pennant Investors Lp 36.60 836,000 0.27% -0.10 30.6 M
Iris Energy Ltd Pennant Investors Lp 46.45 470,000 0.25% NEW 21.8 M
Valmont Industries, Inc. Pennant Investors Lp 413.84 40,000 0.20% NEW 16.6 M
BioXcel Therapeutics Inc Pennant Investors Lp 2.09 83,900 0.20% -0.03 175.4 K
Kalaris Therapeutics Inc. Pennant Investors Lp 5.92 215,700 0.19% 0.00 1.3 M
Core Scientific Inc - Ordinary Shares - New Pennant Investors Lp 17.08 500,000 0.18% NEW 8.5 M
Seres Therapeutics Inc Pennant Investors Lp 17.90 292,300 0.17% -0.02 5.2 M
Enanta Pharmaceuticals Inc Pennant Investors Lp 14.09 35,100 0.17% 0.00 494.6 K
Altimmune Inc Pennant Investors Lp 5.31 109,800 0.15% 0.00 583.0 K
Arcutis Biotherapeutics Inc Pennant Investors Lp 31.16 170,900 0.15% 0.00 5.3 M
Coherus Biosciences Inc Pennant Investors Lp 1.23 168,100 0.15% 0.00 206.8 K
Compass Therapeutics Inc Pennant Investors Lp 5.54 199,000 0.14% 0.00 1.1 M
Fate Therapeutics Inc Pennant Investors Lp 1.10 146,100 0.13% 0.00 160.7 K
Agenus Inc Pennant Investors Lp 4.06 469,600 0.11% 0.00 1.9 M
uniQure N.V. Pennant Investors Lp 22.74 48,500 0.10% 0.00 1.1 M
Nurix Therapeutics Inc Pennant Investors Lp 18.02 56,800 0.08% -0.01 1.0 M
Travere Therapeutics Inc Pennant Investors Lp 35.33 55,800 0.07% NEW 2.0 M
Macrogenics Inc Pennant Investors Lp 1.38 43,800 0.07% 0.00 60.4 K
Allogene Therapeutics Inc Pennant Investors Lp 1.44 128,400 0.06% 0.00 184.9 K
Erasca Inc Pennant Investors Lp 3.19 166,200 0.06% 0.00 530.2 K
Transdigm Group Incorporated Pennant Investors Lp 1360.10 32,371 0.06% -0.02 44.0 M
Zymeworks BC Inc Pennant Investors Lp 26.52 38,700 0.06% 0.00 1.0 M
Arcturus Therapeutics Holdings Inc Pennant Investors Lp 6.83 13,100 0.05% 0.00 89.5 K
Zentalis Pharmaceuticals Inc Pennant Investors Lp 1.40 32,400 0.05% 0.00 45.4 K
Replimune Group Inc Pennant Investors Lp 10.53 30,500 0.04% 0.00 321.2 K
Micron Technology Inc. Pennant Investors Lp 226.65 431,000 0.04% 0.01 97.7 M
Novavax, Inc. Pennant Investors Lp 6.86 60,300 0.04% 0.00 413.7 K
Vertiv Holdings Co - Ordinary Shares - Class A Pennant Investors Lp 182.54 115,000 0.03% NEW 21.0 M
Agios Pharmaceuticals Inc Pennant Investors Lp 27.42 15,100 0.03% 0.00 414.0 K
Arcus Biosciences Inc Pennant Investors Lp 25.26 23,700 0.03% 0.00 598.7 K
Relay Therapeutics Inc Pennant Investors Lp 8.00 42,400 0.03% -0.01 339.2 K
GE Vernova Inc. Pennant Investors Lp 629.11 60,000 0.02% NEW 37.7 M
Amazon.com Inc. Pennant Investors Lp 229.11 240,000 0.00% 0.00 55.0 M
Alphabet Inc - Ordinary Shares - Class A Pennant Investors Lp 317.62 183,000 0.00% 0.00 58.1 M
Microsoft Corporation Pennant Investors Lp 480.84 80,000 0.00% 0.00 38.5 M
View All The Superstar Shareholder Portfolios